It is estimated that 90% of CVD is preventable.[3] Prevention of atherosclerosis involves improving risk factors through: healthy eating, exercise, avoidance of tobacco smoke and limiting alcohol intake.[1] Treating risk factors, such as high blood pressure, blood lipids and diabetes is also beneficial.[1] Treating people who have strep throat with antibiotics can decrease the risk of rheumatic heart disease.[4] The effect of the use of aspirin in people who are otherwise healthy is of unclear benefit.[5][6]

Cardiovascular diseases are the leading cause of death globally.[1] This is true in all areas of the world except Africa.[1] Together they resulted in 17.9 million deaths (32.1%) in 2015, up from 12.3 million (25.8%) in 1990.[7][2]Deaths, at a given age, from CVD are more common and have been increasing in much of the developing world, while rates have declined in most of the developed world since the 1970s.[8][9] Coronary artery disease and stroke account for 80% of CVD deaths in males and 75% of CVD deaths in females.[1] Most cardiovascular disease affects older adults. In the United States 11% of people between 20 and 40 have CVD, while 37% between 40 and 60, 71% of people between 60 and 80, and 85% of people over 80 have CVD.[10] The average age of death from coronary artery disease in the developed world is around 80 while it is around 68 in the developing world.[8] Disease onset is typically seven to ten years earlier in men as compared to women.[11]

Risk factors

There are many risk factors for heart diseases: age, gender, tobacco use, physical inactivity, excessive alcohol consumption, unhealthy diet, obesity, genetic predisposition and family history of cardiovascular disease, raised blood pressure (hypertension), raised blood sugar (diabetes mellitus), raised blood cholesterol (hyperlipidemia), psychosocial factors, poverty and low educational status, and air pollution.[13][14][15][16] While the individual contribution of each risk factor varies between different communities or ethnic groups the overall contribution of these risk factors is very consistent.[17] Some of these risk factors, such as age, gender or family history/genetic predisposition, are immutable; however, many important cardiovascular risk factors are modifiable by lifestyle change, social change, drug treatment (for example prevention of hypertension, hyperlipidemia, and diabetes).[18] People with obesity are at increased risk of atherosclerosis of the coronary arteries.[19]

Genetics

Genetic factors influence the development of cardiovascular disease in men who are less than 55 years-old and in women who are less than 65 years old.[18] Cardiovascular disease in a person's parents increases their risk by 3 fold.[20] Multiple single nucleotide polymorphisms (SNP) have been found to be associated with cardiovascular disease in genetic association studies,[21][22] but usually their individual influence is small, and genetic contributions to cardiovascular disease are poorly understood.[22]

Age

Age is by far the most important risk factor in developing cardiovascular or heart diseases, with approximately a tripling of risk with each decade of life.[23] Coronary fatty streaks can begin to form in adolescence.[24] It is estimated that 82 percent of people who die of coronary heart disease are 65 and older.[25] At the same time, the risk of stroke doubles every decade after age 55.[26]

Multiple explanations have been proposed to explain why age increases the risk of cardiovascular/heart diseases. One of them is related to serum cholesterol level.[27] In most populations, the serum total cholesterol level increases as age increases. In men, this increase levels off around age 45 to 50 years. In women, the increase continues sharply until age 60 to 65 years.[27]

Aging is also associated with changes in the mechanical and structural properties of the vascular wall, which leads to the loss of arterial elasticity and reduced arterial compliance and may subsequently lead to coronary artery disease.[28]

Sex

Men are at greater risk of heart disease than pre-menopausal women.[23][29] Once past menopause, it has been argued that a woman's risk is similar to a man's[29] although more recent data from the WHO and UN disputes this.[23] If a female has diabetes, she is more likely to develop heart disease than a male with diabetes.[30]

Coronary heart diseases are 2 to 5 times more common among middle-aged men than women.[27] In a study done by the World Health Organization, sex contributes to approximately 40% of the variation in sex ratios of coronary heart disease mortality.[31] Another study reports similar results finding that gender differences explains nearly half the risk associated with cardiovascular diseases[27] One of the proposed explanations for gender differences in cardiovascular diseases is hormonal difference.[27] Among women, estrogen is the predominant sex hormone. Estrogen may have protective effects on glucose metabolism and hemostatic system, and may have direct effect in improving endothelial cell function.[27] The production of estrogen decreases after menopause, and this may change the female lipid metabolism toward a more atherogenic form by decreasing the HDL cholesterol level while increasing LDL and total cholesterol levels.[27]

Among men and women, there are notable differences in body weight, height, body fat distribution, heart rate, stroke volume, and arterial compliance.[28] In the very elderly, age-related large artery pulsatility and stiffness is more pronounced among women than men.[28] This may be caused by the women's smaller body size and arterial dimensions which are independent of menopause.[28]

Tobacco

Cigarettes are the major form of smoked tobacco.[1] Risks to health from tobacco use result not only from direct consumption of tobacco, but also from exposure to second-hand smoke.[1] Approximately 10% of cardiovascular disease is attributed to smoking;[1] however, people who quit smoking by age 30 have almost as low a risk of death as never smokers.[32]

Physical inactivity

Insufficient physical activity (defined as less than 5 x 30 minutes of moderate activity per week, or less than 3 x 20 minutes of vigorous activity per week) is currently the fourth leading risk factor for mortality worldwide.[1] In 2008, 31.3% of adults aged 15 or older (28.2% men and 34.4% women) were insufficiently physically active.[1]
The risk of ischemic heart disease and diabetes mellitus is reduced by almost a third in adults who participate in 150 minutes of moderate physical activity each week (or equivalent).[33] In addition, physical activity assists weight loss and improves blood glucose control, blood pressure, lipid profile and insulin sensitivity. These effects may, at least in part, explain its cardiovascular benefits.[1]

Diet

High dietary intakes of saturated fat, trans-fats and salt, and low intake of fruits, vegetables and fish are linked to cardiovascular risk, although whether all these associations are a cause is disputed. The World Health Organization attributes approximately 1.7 million deaths worldwide to low fruit and vegetable consumption.[1] The amount of dietary salt consumed is also an important determinant of blood pressure levels and overall cardiovascular risk.[1] Frequent consumption of high-energy foods, such as processed foods that are high in fats and sugars, promotes obesity and may increase cardiovascular risk.[1] A Cochrane review found that replacing saturated fat with polyunsaturated fat (plant based oils) reduced cardiovascular disease risk. Cutting down on saturated fat reduced risk of cardiovascular disease by 17% including heart disease and stroke.[34] High trans-fat intake has adverse effects on blood lipids and circulating inflammatory markers,[35] and elimination of trans-fat from diets has been widely advocated.[36]
There is evidence that higher consumption of sugar is associated with higher blood pressure and unfavorable blood lipids,[37] and sugar intake also increases the risk of diabetes mellitus.[38] High consumption of processed meats is associated with an increased risk of cardiovascular disease, possibly in part due to increased dietary salt intake.[39]

The relationship between alcohol consumption and cardiovascular disease is complex, and may depend on the amount of alcohol consumed. There is a direct relationship between high levels of alcohol consumption and risk of cardiovascular disease.[1] Drinking at low levels without episodes of heavy drinking may be associated with a reduced risk of cardiovascular disease.[40]
Overall alcohol consumption at the population level is associated with multiple health risks that exceed any potential benefits.[1][41]

Socioeconomic disadvantage

Cardiovascular disease affects low- and middle-income countries even more than high-income countries.[42] There is relatively little information regarding social patterns of cardiovascular disease within low- and middle-income countries,[42] but within high-income countries low income and low educational status are consistently associated with greater risk of cardiovascular disease.[43] Policies that have resulted in increased socio-economic inequalities have been associated with greater subsequent socio-economic differences in cardiovascular disease[42] implying a cause and effect relationship. Psychosocial factors, environmental exposures, health behaviours, and health-care access and quality contribute to socio-economic differentials in cardiovascular disease.
[44] The Commission on Social Determinants of Health recommended that more equal distributions of power, wealth, education, housing, environmental factors, nutrition, and health care were needed to address inequalities in cardiovascular disease and non-communicable diseases.[45]

Air pollution

Particulate matter has been studied for its short- and long-term exposure effects on cardiovascular disease. Currently, PM2.5 is the major focus, in which gradients are used to determine CVD risk. For every 10 μg/m3 of PM2.5 long-term exposure, there was an estimated 8–18% CVD mortality risk.[46] Women had a higher relative risk (RR) (1.42) for PM2.5 induced coronary artery disease than men (0.90) did.[46] Overall, long-term PM exposure increased rate of atherosclerosis and inflammation. In regards to short-term exposure (2 hours), every 25 μg/m3 of PM2.5 resulted in a 48% increase of CVD mortality risk.[47] In addition, after only 5 days of exposure, a rise in systolic (2.8 mmHg) and diastolic (2.7 mmHg) blood pressure occurred for every 10.5 μg/m3 of PM2.5.[47] Other research has implicated PM2.5 in irregular heart rhythm, reduced heart rate variability (decreased vagal tone), and most notably heart failure.[47][48] PM2.5 is also linked to carotid artery thickening and increased risk of acute myocardial infarction.[47][48]

Cardiovascular risk assessment

Existing cardiovascular disease or a previous cardiovascular event, such as a heart attack or stroke, is the strongest predictor of a future cardiovascular event.[49] Age, sex, smoking, blood pressure, blood lipids and diabetes are important predictors of future cardiovascular disease in people who are not known to have cardiovascular disease.[50] These measures, and sometimes others, may be combined into composite risk scores to estimate an individual's future risk of cardiovascular disease.[49] Numerous risk scores exist although their respective merits are debated.[51] Other diagnostic tests and biomarkers remain under evaluation but currently these lack clear-cut evidence to support their routine use. They include family history, coronary artery calcification score, high sensitivity C-reactive protein (hs-CRP), ankle–brachial pressure index, lipoprotein subclasses and particle concentration, lipoprotein(a), apolipoproteins A-I and B, fibrinogen, white blood cell count, homocysteine, N-terminal pro B-type natriuretic peptide (NT-proBNP), and markers of kidney function.[52][53]High blood phosphorus is also linked to an increased risk.[54]

Occupational exposure

Little is known about the relationship between work and cardiovascular disease, but links have been established between certain toxins, extreme heat and cold, exposure to tobacco smoke, and mental health concerns such as stress and depression.[55]

Chemical risk factors

A 2015 SBU-report looking at non-chemical factors found an association for those:[56]

with mentally stressful work with a lack of control over their working situation — with an effort-reward imbalance[56]

who experience low social support at work; who experience injustice or experience insufficient opportunities for personal development; or those who experience job insecurity[56]

Specifically the risk of stroke was also increased by exposure to ionizing radiation.[56] Hypertension develops more often in those who experience job strain and who have shift-work.[56] Differences between women and men in risk are small, however men risk suffering and dying of heart attacks or stroke twice as often as women during working life.[56]

Workplace exposure to silica dust or asbestos is also associated with pulmonary heart disease.There is evidence that workplace exposure to lead, carbon disulphide, phenoxyacids containing TCDD, as well as working in an environment where aluminium is being electrolytically produced, is associated with stroke.[57]

Somatic mutations

As of 2017, evidence suggests that certain leukemia-associated mutations in blood cells may also lead to increased risk of cardiovascular disease. Several large-scale research projects looking at human genetic data have found a robust link between the presence of these mutations, a condition known as clonal hematopoiesis, and cardiovascular disease-related incidents and mortality.[58]

Population-based studies show that atherosclerosis, the major precursor of cardiovascular disease, begins in childhood. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study demonstrated that intimal lesions appear in all the aortas and more than half of the right coronary arteries of youths aged 7–9 years.[60]

This is extremely important considering that 1 in 3 people die from complications attributable to atherosclerosis. In order to stem the tide, education and awareness that cardiovascular disease poses the greatest threat, and measures to prevent or reverse this disease must be taken.

Obesity and diabetes mellitus are often linked to cardiovascular disease,[61] as are a history of chronic kidney disease and hypercholesterolaemia.[62] In fact, cardiovascular disease is the most life-threatening of the diabetic complications and diabetics are two- to four-fold more likely to die of cardiovascular-related causes than nondiabetics.[63][64][65]

The NIH recommends lipid testing in children beginning at the age of 2 if there is a family history of heart disease or lipid problems.[67] It is hoped that early testing will improve lifestyle factors in those at risk such as diet and exercise.[68]

Screening ECGs (either at rest or with exercise) are not recommended in those without symptoms who are at low risk.[69] This includes those who are young without risk factors according to the American Heart Association and the American College of Cardiology.[70] In those at higher risk the evidence for screening with ECGs is inconclusive.[69]Echocardiography and stress testing (myocardial perfusion imaging orcardiac stress testing) are not recommended in those at low risk who do not have symptoms according to the American College of Physicians.[71]

Evidence

Some biomarkers may add to conventional cardiovascular risk factors in predicting the risk of future cardiovascular disease; however, the clinical value of some biomarkers is questionable.[72] Per this study, measured the incremental value of 10 contemporary biomarkers (C-reactive protein, B-type natriuretic peptide,N-terminal pro-atrial natriuretic peptide, aldosterone, renin, fibrinogen, D-dimer, plasminogen-activator inhibitor type 1, and homocysteine; and the urinary albumin-to-creatinine ratio). The C-statistic increased from 0.80 (with age, sex, and conventional risk factors as predictors) to 0.82 (with all predictors). The statistical significant of this increase was not reported.

Screening and selection for primary prevention interventions has traditionally been done through absolute risk using a variety of scores (ex. Framingham or Reynolds risk scores).[73] This stratification has separated people who receive the lifestyle interventions (generally lower and intermediate risk) from the medication (higher risk). The number and variety of risk scores available for use has multiplied, but their efficacy according to a 2016 review was unclear due to lack of external validation or impact analysis.[74] Risk stratification models often lack sensitivity for population groups and do not account for the large number of negative events among the intermediate and low risk groups.[73] As a result, future preventative screening appears to shift toward applying prevention according to randomized trial results of each intervention rather than large-scale risk assessment.

Prevention

Up to 90% of cardiovascular disease may be preventable if established risk factors are avoided.[75][76] Currently practiced measures to prevent cardiovascular disease include:

A low-fat, low-sugar, high-fiber diet including whole grains and fruit and vegetables.[77][79][80] Dietary interventions are effective in reducing cardiovascular risk factors over a year, but the longer term effects of such interventions and their impact on cardiovascular disease events is uncertain.[81]

At least 150 minutes (2 hours and 30 minutes) of moderate exercise per week.[82][83] Exercise-based cardiac rehabilitation reduces risk of subsequent cardiovascular events by 26%,[84] but there have been few high quality studies of the benefits of exercise training in people with increased cardiovascular risk but no history of cardiovascular disease.[85]

Limit alcohol consumption to the recommended daily limits;[77] People who moderately consume alcoholic drinks have a 25–30% lower risk of cardiovascular disease.[86][87] However, people who are genetically predisposed to consume less alcohol have lower rates of cardiovascular disease[88] suggesting that alcohol itself may not be protective. Excessive alcohol intake increases the risk of cardiovascular disease[89][87] and consumption of alcohol is associated with increased risk of a cardiovascular event in the day following consumption.[87]

Decrease body fat if overweight or obese.[94] The effect of weight loss is often difficult to distinguish from dietary change, and evidence on weight reducing diets is limited.[95] In observational studies of people with severe obesity, weight loss following bariatric surgery is associated with a 46% reduction in cardiovascular risk.[96]

Decrease psychosocial stress.[97] This measure may be complicated by imprecise definitions of what constitute psychosocial interventions.[98] Mental stress–induced myocardial ischemia is associated with an increased risk of heart problems in those with previous heart disease.[99] Severe emotional and physical stress leads to a form of heart dysfunction known as Takotsubo syndrome in some people.[100] Stress, however, plays a relatively minor role in hypertension.[101] Specific relaxation therapies are of unclear benefit.[102][103]

Most guidelines recommend combining preventive strategies. A 2015 Cochrane Review found some evidence that interventions aiming to reduce more than one cardiovascular risk factor may have favourable effects on blood pressure, body mass index and waist circumference; however, evidence was limited and the authors were unable to draw firm conclusions on the effects on cardiovascular events and mortality.[104] For adults without a known diagnosis of hypertension, diabetes, hyperlipidemia, or cardiovascular disease, routine counseling to advise them to improve their diet and increase their physical activity has not been found to significantly alter behavior, and thus is not recommended.[105] Another Cochrane review suggested that simply providing people with a cardiovascular disease risk score may reduce cardiovascular disease risk factors by a small amount compared to usual care.[106] However, there was some uncertainty as to whether providing these scores had any effect on cardiovascular disease events. It is unclear whether or not dental care in those with periodontitis affects their risk of cardiovascular disease.[107]

Diet

A diet high in fruits and vegetables decreases the risk of cardiovascular disease and death.[108] Evidence suggests that the Mediterranean diet may improve cardiovascular outcomes.[109] There is also evidence that a Mediterranean diet may be more effective than a low-fat diet in bringing about long-term changes to cardiovascular risk factors (e.g., lower cholesterol level and blood pressure).[110] The DASH diet (high in nuts, fish, fruits and vegetables, and low in sweets, red meat and fat) has been shown to reduce blood pressure,[111] lower total and low density lipoprotein cholesterol[112] and improve metabolic syndrome;[113] but the long-term benefits outside the context of a clinical trial have been questioned.[114] A high fiber diet appears to lower the risk.[115]

The effect of a low-salt diet is unclear. A Cochrane review concluded that any benefit in people with high or normal blood pressure is small if present.[126] In addition, the review suggested that a low-salt diet may be harmful in those with congestive heart failure.[126] However, the review was criticized in particular for not excluding a trial in heart failure where people had low-salt and -water levels due to diuretics.[127] When this study is left out, the rest of the trials show a trend to benefit.[127][128] Another review of dietary salt concluded that there is strong evidence that high dietary salt intake increases blood pressure and worsens hypertension, and that it increases the number of cardiovascular disease events; both as a result of the increased blood pressure and, quite likely, through other mechanisms.[129][130] Moderate evidence was found that high salt intake increases cardiovascular mortality; and some evidence was found for an increase in overall mortality, strokes, and left ventricular hypertrophy.[129]

Medication

Blood pressure medication reduces cardiovascular disease in people at risk,[90] irrespective of age,[131] the baseline level of cardiovascular risk,[132] or baseline blood pressure.[133] The commonly-used drug regimens have similar efficacy in reducing the risk of all major cardiovascular events, although there may be differences between drugs in their ability to prevent specific outcomes.[134] Larger reductions in blood pressure produce larger reductions in risk,[134] and most people with high blood pressure require more than one drug to achieve adequate reduction in blood pressure.[135]

Statins are effective in preventing further cardiovascular disease in people with a history of cardiovascular disease.[136] As the event rate is higher in men than in women, the decrease in events is more easily seen in men than women.[136] In those at risk, but without a history of cardiovascular disease (primary prevention), statins decrease the risk of death and combined fatal and non-fatal cardiovascular disease.[137] A United States guideline recommends statins in those who have a 12% or greater risk of cardiovascular disease over the next ten years.[138]Niacin, fibrates and CETP Inhibitors, while they may increase HDL cholesterol do not affect the risk of cardiovascular disease in those who are already on statins.[139]

Anti-diabetic medication may reduce cardiovascular risk in people with Type 2 Diabetes, although evidence is not conclusive.[140] A meta-analysis in 2009 including 27,049 participants and 2,370 major vascular events showed a 15% relative risk reduction in cardiovascular disease with more-intensive glucose lowering over an average follow-up period of 4.4 years, but an increased risk of major hypoglycemia.[141]

Aspirin has been found to be of only modest benefit in those at low risk of heart disease as the risk of serious bleeding is almost equal to the benefit with respect to cardiovascular problems.[142] In those at very low risk it is not recommended.[143] The United States Preventive Services Task Force recommends against use of aspirin for prevention in women less than 55 and men less than 45 years old; however, in those who are older it is recommends in some individuals.[144]

The use of vasoactive agents for people with pulmonary hypertension with left heart disease or hypoxemic lung diseases may cause harm and unnecessary expense.[145]

Physical activity

A systematic review estimated that inactivity is responsible for 6% of the burden of disease from coronary heart disease worldwide.[146] The authors estimated that 121,000 deaths from coronary heart disease could have been averted in Europe in 2008, if physical inactivity had been removed. A Cochrane review found some evidence that yoga has favourable effects on blood pressure and cholesterol, but studies included in this review were of low quality.[147]

Dietary supplements

While a healthy diet is beneficial, the effect of antioxidant supplementation (vitamin E, vitamin C, etc.) or vitamins has not been shown to protect against cardiovascular disease and in some cases may possibly result in harm.[148][149] Mineral supplements have also not been found to be useful.[150]Niacin, a type of vitamin B3, may be an exception with a modest decrease in the risk of cardiovascular events in those at high risk.[151][152]Magnesium supplementation lowers high blood pressure in a dose dependent manner.[153] Magnesium therapy is recommended for people with ventricular arrhythmia associated with torsades de pointes who present with long QT syndrome as well as for the treatment of people with digoxin intoxication-induced arrhythmias.[154] There is no evidence to support omega-3 fatty acid supplementation.[155]

Management

Cardiovascular disease is treatable with initial treatment primarily focused on diet and lifestyle interventions.[1]Influenza may make heart attacks and strokes more likely and therefore influenza vaccination may decrease the chance of cardiovascular events and death in people with heart disease.[156]

Proper CVD management necessitates a focus on MI and stroke cases due to their combined high mortality rate, keeping in mind the cost-effectiveness of any intervention, especially in developing countries with low or middle income levels.[73] Regarding MI, strategies using aspirin, atenolol, streptokinase or tissue plasminogen activator have been compared for quality-adjusted life-year (QALY) in regions of low and middle income. The costs for a single QALY for aspirin, atenolol, streptokinase, and t-PA were $25, $630–$730, and $16,000, respectively. Aspirin, ACE inhibitors, beta blockers, and statins used together for secondary CVD prevention in the same regions showed single QALY costs of $300–400.

Cardiovascular diseases are the leading cause of death worldwide and in all regions except Africa.[157] In 2008, 30% of all global death was attributed to cardiovascular diseases. Death caused by cardiovascular diseases are also higher in low- and middle-income countries as over 80% of all global deaths caused by cardiovascular diseases occurred in those countries. It is also estimated that by 2030, over 23 million people will die from cardiovascular diseases each year.

It is estimated that 60% of the world's cardiovascular disease burden will occur in the South Asian subcontinent despite only accounting for 20% of the world's population. This may be secondary to a combination of genetic predisposition and environmental factors. Organizations such as the Indian Heart Association are working with the World Heart Federation to raise awareness about this issue.[158]

Research

There is evidence that cardiovascular disease existed in pre-history,[159] and research into cardiovascular disease dates from at least the 18th century.[160] The causes, prevention, and/or treatment of all forms of cardiovascular disease remain active fields of biomedical research, with hundreds of scientific studies being published on a weekly basis.

Recent areas of research include the link between inflammation and atherosclerosis[161] the potential for novel therapeutic interventions,[162] and the genetics of coronary heart disease.[163]

↑Lavigne, PM; Karas, RH (Jan 29, 2013). "The current state of niacin in cardiovascular disease prevention: a systematic review and meta-regression.". Journal of the American College of Cardiology. 61 (4): 440–6. PMID23265337. doi:10.1016/j.jacc.2012.10.030.

↑Zipes DP, Camm AJ, Borggrefe M, et al. (2012). "ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society". Circulation. 114 (10): e385–e484. PMID16935995. doi:10.1161/CIRCULATIONAHA.106.178233.